Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

MOD > Carcinogenesis 2 > Flashcards

Carcinogenesis 2 Flashcards

1
Q

define darwinian evolution and clonal expansion of the intent mutant

A

clonal expansion of the initiating mutant, in order that it will acquires 2nd mutation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define caretaker gene

A

maintain genetic stability by repairing damaged DNA and replication errors and controlling the accuracy of mitosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what feature of tumour cells can mutation in a caretaker gene cause

A

genetic instability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what type of genes are caretaker and gate keeper genes

A

tumour suppressor genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

define gatekeeper gene

A

negative regulators of the cell cycle and proliferation.
positive regulators of apoptosis.
positive regulators of cell differentiation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

do both tumour suppressor genes have to be hit in order for inactivation

A

Yes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how can the promoter region of tumour suppressor genes be inactivated

A

hypermethylation of the CpG islands.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

define epigentic silencing

A

hypermethylation of the CpG islands (promoter region)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is typically the cause of the 1st hit in tumour suppressor genes

A

single point mutation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is typically the cause of the 2nd hit in tumour suppressor genes

A

chromosomal non-disjunction (leads to aneuploidy)

Chromosomal recombination- takes place in meiosis as it combines maternal and paternal genetic material. However in somatic cells during mitosis it can create a daughter cell that is homozygous for the first mutation in TSG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the most common feature of tumour cells

A

aneuploidy- daughter cells have the wrong amount go chromosomes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how do familial cancers predispose individuals with a greater risk of developing a cancer

A

inheritance of a mutant copy of a gatekeeper or caretaker gene, so only require 1 hit to be classes as cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what gene is involved in retinoblastoma and is it a gate keeper of caretaker

A

gatekeeper

RB1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what gene is involved in Li- Fraumeni and is it a gate keeper of caretaker

A

p53

gate keeper and care taker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the principal tumours in Li fraumeni

A

sarcomas and breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what gene is involved in familial adenomatous polyposis and is it a gate keeper of caretaker

A

APC

Gate keeper

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the principal tumours in familial adenomatous polyposis

A

colorectal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what gene is involved in familial breast cancer and is it a gate keeper of caretaker

A

BRAC1/BRAC2

caretaker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are the principal tumours in familial breast cancer

A

breast and ovarian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what gene is involved in hereditary non polyposis colorectal cancer and is it a gate keeper of caretaker

A

hMLH1, hMSH2

care taker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what are the principal tumours in hereditary non polyposis colorectal cancer

A

colon endometerial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

define proto-oncogenes

A

promote cell proliferation, survival, angiogenesis and negative regulation of apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

define oncogenes

A

mutations lead to activated versions or increased expression of proto-oncogenes – GAIN OF FUNCTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

how many mutant oncogene do you need to induce gain of function

A

one- the mutated gene is dominant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what mechanisms activate oncogenes.

A

Translocation of a proto-oncogene from a low transcriptionally active site to an active site - aberrant expression of the oncogene.
E.g. moving the gene to where immunoglobulin’s are present as they are expressed transcpitionally a lot.
Point mutation - substitution of a single base pair can alter an amino acid in the protein causing it to become hyperactive
Amplification by insertion of multiple copies of an oncogene – increased expression.

26
Q

what is the minimum number of genetic alternations required to transform a normal cell into a neoplastic cell

A

3

27
Q

stage by stage tumorigenesis of colorectal cancer.

A

normal epithelium- loss of APC
Hyperplastic epithelium- DNA hypomethylation.
early (activation of K ras)- intermediate(loss of 18q TSG) - late adenomas
loss of p53- carcinoma
invasion and metastases.

28
Q

do tumour cells require a stimulus of positive growth factor before they enter the cell cycle and divide

A

NO

29
Q

define signal transduction (process used to inform cells whether they need to enter the cell cycle )

A

passage of signals from outside the cell, through the almost impervious cell membrane, across the cytoplasm and into the nucleus, where changes in gene expression can take place

30
Q

what factors carries signals about whether a cell needs to enter the cell cycle or not

A

growth factor

31
Q

where are growth factor receptors located

A

on the cell membrane of cells.

32
Q

what is the function of growth factor receptors

A

stimulate a cascade of signalling events that culminate in the nucleus with changes in gene expression.

33
Q

how do oncogenes manipulate RAS in order to continue cell division and proliferation

A

cancer cells carry an activated RAS oncogene mutation where they alter 1 amino acid involved in the cleaving of the phosphate group from GTP. This means that once the RAS oncoprotein has acquired a GTP molecule and shifted into its active state it is unable to revert back to an inactive state

34
Q

do cancer cells respond to negative growth factors which inform cells to leave the cell cycle

A

No

35
Q

what is the function of RB protein

A

key regulator of cell cycle by preventing progression from G1 to S phase.

36
Q

how to tumours prevent responding to negative growth factors

A

Inactivation of RB gene.

37
Q

in a non proliferating cell what is the function of RB

A

in a non proliferating cell does the RB bind to and suppress the activity of transcription factors whose function is to switch on genes required for proliferation

38
Q

In a proliferating cell cell what is the function of RB

A

retinoblastoma protein is phosphorylated, and therefore inactivated, by kinase enzymes that have been switched on via a proliferation signal transduction pathway

39
Q

what negative growth factor activates RB and how does it activate RB

A

transforming growth factor beta (TGFbeta).

stimulating the expression of proteins that inhibit the kinase enzymes that inactivate RB

40
Q

what enzymes inactivate RB

A

kinase

41
Q

when RB is phosphrylated is it active or inactive

A

inactive

42
Q

do tumour cells have a finite replicative ability before they become senesce and die due to loss of telomeres

A

No

43
Q

how to tumour cells have a infinite replicative ability

A

Tumour cells express telomerase that replaces the lost material and cells become immortal.

44
Q

what is the function of telomerase

A

maintain telomere length.

45
Q

what are the telomeres made of

A

Thousands of repeats of hexanucleotide sequence

46
Q

what is the 6 base composition of the telomere hexanucleotide sequence

A

TTAGGG

47
Q

due toe a defiecncy in DNA replication process what is lost every time you replicate DNA

A

part of the telomere.

48
Q

what happens to cells when all the telomere has been lost after numerous replications

A

chromosomes become exposed and are able to fuse with each other resulting in karyotypic chaos, which usually triggers apoptosis

49
Q

how does telomerase replace lost telomeres

A

using an RNA template.

50
Q

when is telomerase typically expressed in normal human cells

A

embryogenesis but expression is lost in cells once they differentiate

51
Q

how do tumour cells resist apoptosis

A

P53 induces cell cycle arrest to allow repair of DNA damage
But also induces apoptosis if too much damage
TP53 inactivation leading to loss of apoptotic response is the most common genetic abnormality in human tumours

52
Q

what gene is involved in apoptosis

A

p53

53
Q

what size tumours need a blood supply

A

> 2 mm

54
Q

what is the name of the transcription factor which induces VEGF, and what causes the transcription factor to be stimulated

A

HIF-1 transcription factor

hypoxia

55
Q

what is the function of VEGF

A

construct new capillaries and vessels

actively recruit endothelial cells that proceed to construct new capillaries and vessels

56
Q

Can malignant cells invade other tissue and detach from their own

A

Yes

57
Q

what holds cells together

A

E cadherin

58
Q

how does e cadherin become inactivated in genes

A

mutation/hypermethylation of the gene

59
Q

what is epithelial mesenchymal transition

A

Mesenchymal cells are motile and secrete proteases - allows them to break through basement membrane and invade the underlying stroma

60
Q

what is the clinical application of tumour markers

A 
screening
diagnosis
prognosis
therapy
monitoring
61
Q

example of a tumour marker which is predictive for prognosis.

A
  • Gene expression profiling of acute myeloid leukaemia (AML) subtypes
  • AML subtypes with different translocations (t(11q23)/MLL, t(8;21), t(15;17), inv(16), and AML with complex aberrant karyotypes) are clearly distinguished based on differential genomic expression from 749 probe sets
62
Q

example of a tumour marker which is a predicitve marker for therapeutic response.

A
  • HER2 (erbB2/neu) codes for a +ve growth factor receptor
  • Overexpression found in ~30% of breast tumours (gene amplification)
  • Makes cells more responsive to, or independent of, +ve growth factors
  • Herceptin is an antibody drug targeted to HER2 and dampens the effects of an overactive HER2 receptor
  • Only patients with HER2 overexpression have Herceptin treatment as individuals without overactive HER2 receptors will have no beneficial effect

MOD (19 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions